Eighteen Months on STEM OPT, but No Independent Record: How a Biomedical Engineer Built an Approved O-1A Case

O-1A for biomedical engineers: The engineer had helped validate wearable sensors, improve movement analysis software, and prepare a rehabilitation device for wider use. Most of the evidence remained inside her employer. The case became credible after two technical contributions were reconstructed, a permission-safe validation method was published, patent inventorship was documented, other researchers used her tools, and the proposed U.S. engagements were aligned with an O-1A agent petition.

This is an anonymized composite case study drawn from completed professional profile development and O-1A petition work. It does not identify a specific client. Names, employers, laboratories, dates, device designs, patent details, publication titles, user organizations, performance values, contracts, and selected implementation facts have been combined, withheld, or adjusted to protect privacy, intellectual property, research participants, and confidential business information.

Case at a glance

Profession	Case details
Profession	Biomedical engineering, wearable sensing, rehabilitation technology, movement analysis, medical-device software, design verification, and human-factors support
Starting point	A master’s-trained biomedical engineer on STEM OPT with approximately five years of combined graduate and industry experience, eighteen months remaining, two coauthored papers, strong employer records, and little recognition outside the company
Expert specialization	Validation and translation of wearable monitoring and rehabilitation devices for gait, mobility, and home-exercise assessment
Main profile problem	The record showed product-development work but did not identify the engineer’s personal technical decisions, prove use beyond one employer, or connect the evidence to a workable U.S. petitioner and engagement structure
Profile-building period	Approximately twelve months before filing, followed by petition preparation and adjudication
What already existed	Sensor-validation reports, algorithm test files, calibration logs, design-review records, aggregate usability results, two coauthored papers, an invention disclosure, performance reviews, and supervisors able to confirm the work
What Advance My Profile organized or developed	A contribution chronology, a Wearable Rehabilitation Validation and Translation Method, two first-author technical works, a public validation toolkit, patent-inventorship evidence, conference presentations, completed peer review and judging, independent-use records, published material, expert letters, and a U.S. agent petition with contracts and an itinerary
O-1A evidence emphasized	Original contributions, authorship, judging, published material about the beneficiary, and critical roles for distinguished organizations, supported by a separate totality analysis
What was deliberately not pursued	Patient testimonials, raw clinical records, paid publicity, open memberships, internal design reviews as judging, a patent application as automatic proof of major significance, unrelated awards, high-remuneration evidence that did not compare well, and claims that the devices diagnosed disease or improved recovery
Petition result	USCIS approved the O-1A petition without issuing a Request for Evidence. The approval authorized only the petitioned temporary work during the approved validity period; it did not grant permanent residence or unrestricted employment authorization.

The deadline was visible, but the evidentiary problem was not

At intake, the client believed that eighteen months was enough because her employer considered her indispensable. She had supported a wearable gait-monitoring platform, improved sensor calibration, helped prepare verification files, and worked with rehabilitation specialists. Her manager described her as the engineer who understood both the hardware and the movement data. The curriculum vitae still looked like ordinary medical-device employment.

The public record was thin. Two papers from graduate school listed her as a middle author. The company website discussed the product but not her role. Patent counsel had received an invention disclosure, yet no application had been filed. She had attended conferences without presenting, had never reviewed a manuscript, and had no independent article about her work. The company owned the code, datasets, device drawings, and regulatory files.

The time limit changed the order of work. A slow publication-first strategy would have left the petition dependent on future events. A publicity-first strategy would have created weak evidence. The profile audit therefore began with completed engineering work and asked which contributions could be proved, discussed lawfully, and connected to outside professional use within the available period.

Legal context: USCIS evaluates O-1A cases in the sciences, education, business, or athletics through the regulatory evidence categories and the record as a whole. The petitioner must also show that the beneficiary will continue work in the area of extraordinary ability. STEM OPT, by contrast, depends on qualifying employment, an E-Verify employer, and a Form I-983 training plan. The two records were kept separate so that professional development did not become unauthorized employment or an inconsistent work history.

A compressed plan still began with authorship, not publicity

The first eight weeks were used to reconstruct authorship. We reviewed design-control records, version histories, calibration notebooks, validation protocols, issue trackers, code-review notes, invention disclosures, test reports, and meeting minutes. Each project was divided into established methods, team decisions, employer-owned work, and the client’s own technical judgment.

The audit identified two contribution files. The first concerned gait-monitoring reliability when wearable sensors were placed by different users and used at different walking speeds. The second concerned home-exercise feedback when movement signals were incomplete, noisy, or outside the model’s reliable range. Both files showed the same professional pattern: the client made wearable data more dependable before the software presented a result to a clinician or user.

Several items were removed. A product launch had performed well commercially, but the client had not controlled pricing, sales, or market strategy. A pilot site reported positive patient comments, but the comments were not collected for research and did not prove the engineer’s influence. An internal innovation nomination was open to all employees and had no external jury. None of these became a central claim.

The expert position narrowed to wearable rehabilitation validation and translation

The original narrative covered biomedical engineering, digital health, artificial intelligence, rehabilitation, biomechanics, medical devices, remote monitoring, and healthcare access. That scope made every achievement look smaller. It also encouraged claims that exceeded the client’s actual role.

The final expert position focused on validating and translating wearable monitoring and rehabilitation devices for gait, mobility, and home-exercise assessment. The word translation referred to the engineering work required to move a sensor system from controlled testing toward reliable use in rehabilitation settings. It did not mean that the client practiced physical therapy, made diagnoses, selected treatment, or replaced clinical judgment.

This position connected the two contribution files, the patent work, the publications, the public toolkit, and the proposed U.S. engagements. It also created a defensible boundary: the client worked on sensor quality, algorithm verification, uncertainty, usability, and technical documentation; clinicians retained responsibility for patient care and clinical interpretation.

Technical context: FDA materials on digital health technologies, medical-device software validation, and human factors emphasize intended use, data quality, verification, validation, users, use environments, and use-related risk. NIBIB research programs also show continuing work on wearable sensors, movement analysis, rehabilitation robotics, and mobile monitoring. These sources described the field. They did not prove the client’s individual recognition.

The Wearable Rehabilitation Validation and Translation Method made the work transferable

We organized the client’s completed engineering practice into a seven-stage method. The name described a repeatable sequence derived from her own work. It was not presented as an FDA standard, a clinical protocol, or a substitute for the manufacturer’s design-control and regulatory obligations.

Stage	What the client developed	Evidence preserved
1. Intended use and evidence boundary	Defined the user, setting, movement, device output, excluded interpretation, foreseeable misuse, and evidence needed before a result could be presented.	Design inputs, intended-use notes, risk files, user stories, clinical-adviser comments, and scope approvals.
2. Sensor placement and calibration	Specified placement tolerances, orientation checks, calibration movements, synchronization rules, signal-quality thresholds, and conditions requiring a repeated setup.	Calibration logs, placement diagrams, bench tests, orientation studies, synchronization traces, and test scripts.
3. Reference and labeling plan	Matched each output to an appropriate reference, labeling rule, reviewer process, missing-data rule, and disagreement procedure.	Motion-capture comparisons, pressure-walkway data, annotation guides, reviewer records, and adjudication notes.
4. Performance and uncertainty testing	Tested accuracy across speeds, body types, device versions, movement variations, and known failure conditions, with confidence or abstention rules.	Test matrices, subgroup summaries, error analyses, confidence thresholds, regression results, and failure logs.
5. Human factors and use-error review	Observed setup, charging, placement, calibration, feedback comprehension, and recovery from common errors for intended users and environments.	Usability plans, task analyses, observation records, de-identified findings, training revisions, and risk controls.
6. Controlled release and verification	Linked software and hardware versions to acceptance criteria, traceability, unresolved issues, release decisions, and post-release checks.	Requirements traceability, version records, verification reports, release notes, issue closures, and quality approval.
7. Transfer and monitoring	Converted the work into training, blank protocols, reporting templates, known-limitations guidance, and a process for reviewing later failures or drift.	Training records, public toolkit, user requests, adaptation notes, monitoring summaries, and independent-use letters.

Contribution one: the gait platform became reliable across real placement variation

The employer’s lower-limb wearable used inertial sensors to identify steps and estimate gait measures during rehabilitation assessments. Early validation was strong when trained engineers placed the sensors. Performance became less consistent when therapists, technicians, and study staff applied the devices under normal time pressure. Orientation changes, loose straps, different walking speeds, assistive devices, and interrupted calibration produced sessions that looked complete but contained unreliable outputs.

The client redesigned the setup and verification layer. She created a placement-quality index using orientation, motion range, signal saturation, synchronization, and calibration consistency. She added a short functional calibration sequence, separated low-confidence sessions from valid sessions, and required the software to withhold selected metrics when the signal did not meet defined conditions. She also revised the validation set so it included slow gait, asymmetric gait, and common placement deviations rather than only ideal laboratory recordings.

The record preserved her design notes, code-history extracts, test plans, comparison data, and approval trail. A rehabilitation scientist confirmed that the client selected the error conditions and designed the repeat-calibration logic. The quality manager confirmed that the changes entered the controlled product-development process. A separate engineer confirmed that the client’s work was not limited to executing a protocol written by others.

Validation measure	Earlier record	Later record	Evidence boundary
Sessions passing the full signal-quality check on first setup	Approximately 82 percent	Approximately 94 percent after the placement and calibration changes	Measured in the defined validation and pilot records; not a claim about all users or all devices.
Median absolute timing error for identified gait events	About 55 milliseconds	About 24 milliseconds in the later comparison set	Compared with the selected reference system under the stated test conditions.
Absolute error in the selected gait-symmetry measure	Approximately 8.6 percentage points	Approximately 3.7 percentage points	The metric supported technical validation; it did not diagnose impairment or prescribe treatment.
Sessions requiring manual relabeling or engineering review	About 21 percent	About 8 percent	The result reflected revised setup, labeling, and confidence rules operating together.

The petition did not claim that improved measurement caused faster recovery, prevented falls, or replaced a clinical gait assessment. It showed that the client identified a practical reliability problem, designed the technical controls, verified the change, and helped move the method into repeated use.

Contribution two: home-exercise feedback stopped pretending that every signal was usable

A second project involved a wearable and mobile application used to record upper-limb and shoulder exercises outside the clinic. The early system counted repetitions and generated movement feedback. It performed well during supervised demonstrations but produced avoidable false prompts when the device shifted, the user paused, a movement was incomplete, or the signal pattern fell outside the training data.

The client changed the output logic from forced classification to confidence-aware feedback. She developed signal-integrity checks, segmented repetitions only after minimum movement conditions were met, and introduced an uncertain category that routed selected sessions for later review instead of issuing a definitive prompt. She worked with therapists to define which feedback could be automated and which findings required clinical interpretation.

Human-factors testing also changed the physical setup. The team simplified the strap orientation, added a visual placement cue, revised calibration instructions, and tested whether intended users understood when the device was ready. The client documented use errors, engineering responses, and residual limitations. She did not claim authorship of the entire application or the therapy program.

Operational measure	Earlier record	Later record	Evidence boundary
Recorded sessions producing analyzable movement segments	Approximately 69 percent	Approximately 88 percent after the revised setup and quality gate	Applied to the specified exercises and device version.
False or unsupported automated feedback alerts	About 27 percent of reviewed alerts	About 10 percent in the later verification set	The review used predefined error categories and did not measure treatment effectiveness.
Calibration-related support events per 100 active users	Approximately 16	Approximately 6 over the later observation period	The comparison excluded unrelated device and account issues.
Uncertain sessions correctly withheld from automatic feedback	No formal abstention measure	More than four-fifths of the predefined uncertain cases	Withholding was treated as a safety and reliability feature, not a failed prediction.

Patent work documented conception without turning a filing receipt into acclaim

The client had submitted an invention disclosure covering the placement-quality index, calibration checks, and confidence-aware output logic. The first profile plan described this as a future patent. That wording was removed. Patent counsel reviewed the disclosure, inventor interviews, claim concepts, and development history before the employer filed a U.S. nonprovisional application naming the client as a co-inventor.

The evidence file included the signed invention disclosure, dated diagrams, claim-mapping notes, inventor declaration, filing receipt, and a letter from patent counsel explaining the client’s contribution to conception. The employer retained ownership. The petition did not describe the application as an issued patent or assume that the claims would be allowed.

The application supported authorship of the technical concept. Major significance came from implementation, measured use, independent technical assessment, and the way the controls changed the employer’s validation process. This distinction prevented ordinary patent language from carrying more weight than the evidence allowed.

Inventorship context: USPTO materials explain that each named inventor must contribute to the conception of at least one claimed invention. Joint inventors need not make the same type or amount of contribution. The case therefore documented the client’s specific conception rather than relying only on her name on an application.

The publication program used completed work and available rights

The client initially proposed four papers in twelve months. The plan was reduced to two substantial works and one public technical asset. Each subject was screened for data ownership, employer permission, research oversight, confidentiality, and the client’s actual authorship.

The first article addressed wearable gait validation under placement and speed variation. It explained the test design, error categories, calibration sequence, confidence rules, and reporting limits without naming the employer or disclosing protected device architecture. A peer-reviewed biomedical engineering journal accepted the paper after revision. The client was first author, and the corresponding author confirmed her role in study design, analysis, and drafting.

The second work was a conference paper on confidence-aware movement feedback for home rehabilitation. It used an authorized, de-identified verification dataset and separated algorithm performance from clinical effectiveness. The paper was selected for an oral presentation and published in the conference proceedings.

The client’s earlier coauthored papers had a modest citation count. The petition did not compare her total with senior professors. It mapped independent citations that used her calibration or validation work, requests for the protocol, conference selection, and later use of the public toolkit. Influence was shown through specific professional reliance, not a large number without context.

A public validation toolkit created use outside the employer

The employer could not release source code, device drawings, patient-linked data, or internal acceptance thresholds. A public asset was therefore built from nonproprietary material. The Wearable Rehabilitation Validation Toolkit contained a blank intended-use worksheet, sensor-placement test cases, synthetic signal-quality examples, a reference-comparison template, an uncertainty-reporting checklist, and a model card for movement outputs.

The toolkit did not reproduce the company’s product or enable clinical use. It taught a validation process. A university movement laboratory used the placement-variation checklist in a student project. A small rehabilitation-device company adapted the uncertainty-reporting template for an internal review. A biomedical engineering course incorporated two synthetic examples into a design verification assignment.

Evidence point	Completed record	Why it mattered
Clear ownership	Repository history, license, authorship note, employer permission, and a clean-room development memorandum	Showed that the public material belonged to the client and did not copy protected company assets.
Independent use	User letters, course materials, issue records, adaptation notes, and workshop attendance	Established professional reliance beyond downloads or anonymous repository activity.
Technical boundaries	Synthetic data, non-device disclaimer, excluded clinical claims, and known-limitations section	Reduced the risk that a public resource would be mistaken for a validated medical device or treatment tool.
Continuing maintenance	Version history, resolved issues, revised examples, and release notes	Showed that the resource remained an active part of the client’s professional work.

Conference visibility led to completed peer evaluation

Professional visibility followed the technical work. The client delivered the accepted oral conference presentation, joined a rehabilitation-engineering panel, and taught a short workshop on sensor placement and uncertainty reporting. The evidence archive retained programs, acceptance notices, recordings where permitted, audience information, and organizer letters.

After the first-author paper and conference presentation, journal editors invited her to review manuscripts on wearable sensing, movement classification, and rehabilitation technology. She completed seven reviews for three journals and reviewed nine abstracts for a biomedical engineering meeting. She also served on a university rehabilitation-device design competition panel after the organizers reviewed her publications and product-validation record.

The petition used only completed reviews. Internal design reviews, employee interviews, and routine code review were excluded because they were part of her job, not evaluation of others in the field. The evidence included invitations, completed-review confirmations, editor records, criteria supplied to judges, and the subjects reviewed.

Independent coverage focused on the engineer, not a product announcement

A biomedical-technology publication interviewed the client after her conference presentation and reviewed the public toolkit, patent application, and first-author paper. The resulting article discussed her work on placement variation, uncertainty, and home-rehabilitation data quality. It identified her by name and included comments from an independent rehabilitation engineer.

A second trade outlet included her in a technical feature about engineers moving wearable devices from laboratory validation toward home use. The petition did not count employer press releases, reposted announcements, sponsored profiles, or articles that mentioned only the company. Publication records included the writers, editorial contacts, outlet information, article copies, and evidence that the coverage was not purchased.

Critical-role evidence explained why the employer depended on her work

The client’s title was Biomedical Engineer II, which did not appear senior. The evidence focused on responsibility and organizational consequence. She led the cross-functional verification workstream for the employer’s main rehabilitation platform, maintained the sensor-validation traceability file, and served as the engineering contact for rehabilitation-science and quality teams.

The company’s reputation was documented separately through completed funding, research partnerships, regulatory submissions, product deployments, and independent industry coverage. Letters from the chief technology officer, quality leader, and an external rehabilitation partner explained the client’s work, the decisions assigned to her, and the effect of the validation controls on release readiness. The letters cited source records rather than using general praise.

The file did not claim that she controlled clinical strategy, regulatory approval, company financing, or all product performance. Her critical role concerned wearable data quality, validation, and technical translation. That narrower claim was easier to prove and matched the proposed O-1A work.

The U.S. agent structure began after STEM OPT, not beside it

The immigration plan had to separate current authorized work from future O-1A engagements. During STEM OPT, the client remained employed by the E-Verify medical-device company under the existing employer relationship and Form I-983. Professional articles, conference participation, and peer review were documented as employer-approved or independent professional activities and were reviewed for status compliance by immigration counsel and the designated school official where appropriate.

The O-1A petition was filed by a U.S. agent for engagements that began on or after the requested O-1A start date. The agent agreement authorized the petitioner to coordinate the engagements and receive notices. The itinerary did not list vague consulting. It identified the work, dates, locations, deliverables, compensation terms, and relationship among the agent and the end clients.

Engagement	Petitioned work	Completed documentation
Wearable-device company	Continued engineering work on sensor validation, device-software verification, risk controls, and technical documentation for the rehabilitation platform	Signed employment offer and employer-agent agreement beginning on the requested O-1A start date.
Rehabilitation research institute	Defined collaboration on validation protocols, movement sensor test design, staff training, and nonclinical engineering analysis	Signed statement of work, institutional letter, milestones, data access limits, and confirmation that clinical decisions remained with licensed staff.
Medical-device incubator	Three technical workshops and office-hour sessions on wearable validation, uncertainty reporting, and human-factors evidence	Executed services agreement, workshop dates, curriculum, fee terms, and participant scope.
Biomedical engineering conference	Invited tutorial on translating wearable movement sensors from controlled tests to intended-use environments	Invitation, program commitment, honorarium terms, and scheduled date within the petition period.

An appropriate peer-group consultation addressed the work described in the itinerary. The petition did not ask USCIS to approve open ended self-employment or work unrelated to the client’s wearable rehabilitation specialization.

The evidence record addressed five O-1A areas without weak add-ons

Evidence area	How the completed record addressed it	Important limitation
Original scientific or business-related contributions of major significance	Two attributable wearable-rehabilitation contributions, controlled adoption, measured validation results, patent-inventorship evidence, outside technical use, and independent expert analysis	The petition did not claim authorship of the entire devices, clinical programs, or company products.
Authorship of scholarly or professional articles	A first-author journal article, a conference paper and proceedings record, and earlier coauthored biomedical engineering work	Only technical works grounded in completed work and authorized data were used.
Participation as a judge of the work of others	Seven completed journal reviews, nine conference abstracts, and a completed rehabilitation-device design competition panel	Internal design reviews and ordinary employee evaluation were excluded.
Published material about the beneficiary	Independent trade coverage focused on the client’s validation work, public toolkit, and technical approach	Employer announcements, sponsored posts, and articles about the product alone were not counted.
Critical or essential role for distinguished organizations	Cross-functional verification leadership for the employer’s principal rehabilitation platform and defined work for respected research and innovation organizations	Company reputation and the client’s personal role were documented separately.
High salary or other significantly high remuneration	Reviewed but not claimed	The comparison did not provide a sufficiently clear advantage over similarly situated biomedical engineers in the relevant labor market.
Awards and selective memberships	Reviewed but not claimed	The record contained no qualifying individual award or membership requiring outstanding achievement judged by recognized experts.

The totality analysis connected recognition to continuing work

Meeting several evidence categories did not end the analysis. The petition explained why the full record showed recognition above ordinary biomedical-device employment in the defined area. The client had authored the technical controls, those controls entered a controlled product process, independent professionals used her public method, editors and organizers selected her to evaluate others, and outside publications discussed her work by name.

The record also showed continuity. The two contribution files, patent application, articles, toolkit, reviews, media, and petitioned engagements all concerned wearable monitoring and rehabilitation-device validation. The client was not combining unrelated achievements to reach a criterion count. The U.S. work continued the same specialized activity documented in the past record.

Her early-career stage was addressed directly. The petition did not compare her with every senior biomedical engineering professor or device-company executive. It showed that, within a narrow technical area, independent organizations had already relied on her work, requested her judgment, and engaged her for continuing activity.

USCIS approved the O-1A petition without an RFE

The petition was filed while the client still had several months of STEM OPT employment authorization. USCIS approved the O-1A classification for the requested engagement period without issuing a Request for Evidence. The employer and agent implemented the approved start-date transition rather than treating the filing receipt as work authorization.

The approval did not grant permanent residence, unrestricted employment authorization, or permission to work for any organization. The beneficiary remained limited to the petitioned area and approved engagements, subject to the applicable immigration rules. Any material change required review by immigration counsel.

The completed evidence archive was retained for later assessment of EB-1A or EB-2 NIW eligibility. The case study does not claim that O-1A approval automatically established either immigrant classification.

The profile moved from employer-dependent evidence to attributable professional authority

Profile dimension	Starting record	Completed transformation
Professional identity	General biomedical engineer working on a wearable product	Engineer specializing in validation and translation of wearable monitoring and rehabilitation devices
Technical contributions	Tasks described through job duties and company product language	Two contribution files showing the problem, personal decision, implementation, measurement, and independent confirmation
Research and authorship	Two older middle-author papers	First-author journal article, conference paper, oral presentation, and a public validation toolkit
Intellectual property	Unfiled internal invention disclosure	Employer-filed nonprovisional application with documented conception and co-inventorship
Independent recognition	No judging, limited speaking, no personal media	Completed journal and conference review, competition judging, invited presentations, and independent published material
Use outside the employer	No documented external reliance	University, startup, course, and research-institute use of permission-safe tools and methods
Petitioner structure	STEM OPT employment record only	U.S. agent petition with defined contracts, itinerary, consultation, and post-OPT start dates
Petition readiness	Strong internal work without a coherent O-1A record	Five supported evidence areas and a totality narrative tied to continuing U.S. work

What the case did not claim

• The wearable devices diagnosed disease, selected therapy, or replaced a physician, therapist, or other licensed professional.
• The client invented every part of the employer’s hardware, software, algorithms, clinical workflow, or commercial product.
• A pending patent application proved major significance without implementation and independent evidence.
• Improved measurement accuracy caused better patient outcomes, shorter rehabilitation, fewer falls, or lower healthcare costs.
• Conference attendance, routine internal review, open memberships, certificates, or paid media established extraordinary ability.
• STEM OPT permitted any outside employment or engagement listed in the later O-1A petition.
• O-1A approval established permanent residence, EB-1A eligibility, or EB-2 NIW eligibility.

Profession specific lessons from the case

Biomedical engineering Profile Building worked best when the public record grew from controlled technical work. The patent, articles, talks, and judging were useful because they traced back to real design and validation decisions. They did not substitute for those decisions.

Wearable devices require disciplined boundaries. A movement metric is not automatically a diagnosis. A home-exercise prompt is not treatment. Strong Professional Profile Development stated the intended use, data conditions, uncertainty, user role, and clinical limits with the same care used to describe accuracy.

Employer-owned evidence can still support Professional Profile Advancement when the archive preserves authorship through version history, role confirmation, approved extracts, aggregate results, patent records, and independent witnesses. Copying confidential code or patient-linked data would have weakened the case and created separate risks.

Time pressure did not justify artificial publicity. The compressed sequence succeeded because contribution reconstruction came first, publication and public tools came second, and recognition activities followed demonstrated expertise. That order produced Expert Positioning that was credible to technical readers as well as immigration adjudicators.

The petitioner structure was part of Petition Readiness. An O-1A profile and a vague itinerary do not support each other. The agent agreement, contracts, consultation, dates, deliverables, and continuing area of work had to match the evidence record.

How Advance My Profile approached the work

Advance My Profile organized the professional evidence, contribution chronology, publication strategy, public technical asset, independent-use record, peer-evaluation history, expert positioning, and petition-readiness archive. The work focused on genuine achievements and records that could be checked. It did not manufacture research, patent inventorship, media, judging, clinical results, or institutional interest.

Immigration counsel remained responsible for legal eligibility, status compliance, petitioner structure, consultation, contracts, itinerary, filing, and representation. Patent counsel determined inventorship and filing strategy. The employer, quality system, clinical collaborators, research oversight bodies, and relevant regulators controlled device, data, human-subject, and professional practice requirements.

Frequently asked questions